Literature DB >> 9652445

Genetic basis for protection against experimental vaginal candidiasis by peripheral immunization.

R D Mulero-Marchese1, K J Blank, T G Sieck.   

Abstract

In these studies, significant protection against experimental vaginal candidiasis after a subcutaneous immunization with Candida albicans extract was achieved in BALB/c mice but not in C57BL/6 (B6) mice. Protection from vaginal candidiasis was transferred to naive BALB/c mice by a population of spleen cells derived from immunized BALB/c mice. Removal of CD3 or CD4 but not CD8 T cells before transfer completely abrogated resistance to vaginal candidiasis. Recombinant inbred (RI) strains of mice derived from BALB/c and B6 strains were used for mapping loci that might be responsible for regulating vaginal protection after subcutaneous immunization. Linkage analysis using microsatellite-based genome mapping in these RI strains revealed four candidate loci on chromosomes 3, 7, 8, and 18 that exhibit statistically significant linkage to the strain distribution pattern. These results may contribute to the understanding of host genetic factors controlling the immune response to vaginal infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9652445     DOI: 10.1086/515602

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  4 in total

Review 1.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

2.  Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans.

Authors:  F de Bernardis; G Santoni; M Boccanera; E Spreghini; D Adriani; L Morelli; A Cassone
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.

Authors:  Paul L Fidel; Melissa Barousse; Terri Espinosa; Mercedes Ficarra; Joy Sturtevant; David H Martin; Alison J Quayle; Kathleen Dunlap
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

4.  Immune cell-mediated protection against vaginal candidiasis: evidence for a major role of vaginal CD4(+) T cells and possible participation of other local lymphocyte effectors.

Authors:  Giorgio Santoni; Maria Boccanera; Daniela Adriani; Roberta Lucciarini; Consuelo Amantini; Stefania Morrone; Antonio Cassone; Flavia De Bernardis
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.